How has this study helped patients and
researchers?
This study helped researchers learn more about osimertinib in participants with
advanced NSCLC after it had been approved for use in some countries.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this one study.
Other studies may provide new information or different results.
Further clinical studies with osimertinib are planned.
11 | Clinical Study Results